Loading asset research
Tiziana Life Sciences Ltd. Common Shares
TLSANasdaq · USD · StocksQuote as of · Exchange session not verified$0.96
0.00%
Today
TLSA
Loading 1D prices…
Market cap
$122.2M
Volume
272.9K
52w high
$2.3552w low
$0.87Company profile
Tiziana Life Sciences Ltd. Common Shares
Tiziana Life Sciences Ltd, together with its subsidiaries, engages in the research and development of therapies for neurodegenerative and neuroinflammatory diseases in the United Kingdom and internationally. It develops Foralumab TZLS-401, a human anti-CD3 monoclonal antibody, which is Phase II clinical trial for the treatment of non-active secondary progressive multiple sclerosis, Alzheimer's disease, multi system atrophy, and amyotrophic lateral sclerosis; and TZLS-501, a human anti-IL-6R monoclonal antibody for the treatment of autoimmune and inflammatory diseases. The company is headquartered in London, the United Kingdom.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
London, United Kingdom, United States
Employees
10
Fiscal year end
1231
CIK
1723069
Session & valuation
Open$0.98
Previous close$0.96
Day high$1.00
Day low$0.93
30-day avg. volume949.4K
Outstanding shares120.5M
Diluted EPS-$0.16
Latest annual period
P/E (trailing)-6.00
P/E (forward)-4.81
Price / book—
Beta0.45
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| MISTMilestone Pharmaceuticals Inc. Common Shares | $122M | $1.5M | -4.08% | -$0.75 | -6.67% | Buy |
| PMNProMIS Neurosciences Inc. Common Shares (ON) | $121.6M | $0.00 | — | -$22.61 | +1.19% | Buy |
| OKUROnKure Therapeutics Inc. Class A Common Stock | $125.5M | $0.00 | — | -$4.40 | -5.20% | Buy |
| BMEABiomea Fusion Inc. Common Stock | $125.8M | $0.00 | — | -$1.18 | +2.35% | Buy |
| RFLRafael Holdings Inc. Class B Common Stock | $118.6M | $630K | -3247.46% | -$0.40 | -3.39% | Unrated |